Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
Comorbidity Measures for Use with Administrative Data
1998 • 8,872 citations
Prevalence of Diagnosed Atrial Fibrillation in Adults
2001 • 6,106 citations
Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation
1995 • 2,148 citations
Smearing Estimate: A Nonparametric Retransformation Method
1983 • 1,991 citations
Lifetime Cost of Stroke in the United States
1996 • 823 citations
Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs
1998 • 686 citations
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
2004 • 585 citations
Secular trends in the prevalence of atrial fibrillation: The Framingham study
1996 • 454 citations
Nonparametric Statistics for Health Care Research: Statistics for Small Samples and Unusual Distributions
1998 • 404 citations
Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
1995 • 329 citations
Analysis and implications
1988 • 268 citations
Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database
2001 • 263 citations
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996
2001 • 170 citations
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.
1992 • 131 citations
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation
1998 • 113 citations
Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001
2004 • 107 citations
Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care
1999 • 89 citations
Cost-Effectiveness of Transesophageal Echocardiographic-Guided Cardioversion: A Decision Analytic Model for Patients Admitted to the Hospital With Atrial Fibrillation
1997 • 76 citations
Cost-effectiveness analysis in heart disease, part III: Ischemia, congestive heart failure, and arrhythmias
1995 • 76 citations
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
1998 • 76 citations
Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study
2005 • 75 citations
Cost-Effectiveness of Anticoagulation in Nonrheumatic Atrial Fibrillation in the Primary Prevention of Ischemic Stroke
1998 • 75 citations
Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs
2003 • 75 citations
Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness Issues
1998 • 68 citations
Trends and Outcomes in the Hospitalization of Older Americans for Cardiac Conduction Disorders or Arrhythmias, 1991–1998
2001 • 67 citations
Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation
1999 • 66 citations
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980–1999
2005 • 62 citations
Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome.
1993 • 60 citations
Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathways
1991 • 50 citations
Cost Analysis of a Managed Care Decentralized Outpatient Pharmacy Anticoagulation Service
2004 • 46 citations
Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK (Heart (2004) 90, (286-292))
2007 • 40 citations
Cost Comparison of Radiofrequency Modification and Ablation of the Atrioventricular Junction in Patients With Chronic Atrial Fibrillation
1997 • 32 citations
Second Line Pharmacological Management of Paroxysmal and Persistent Atrial Fibrillation in France: A Cost Analysis
2000 • 24 citations
Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter
2000 • 15 citations